Review



anti human fd goat polyclonal antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems anti human fd goat polyclonal antibody
    FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing <t>polyclonal</t> antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.
    Anti Human Fd Goat Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+fd+goat+polyclonal+antibody/pm29450541-82-6-12?v=R%26D+Systems
    Average 94 stars, based on 10 article reviews
    anti human fd goat polyclonal antibody - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "Induction of Ocular Complement Activation by Inflammatory Stimuli and Intraocular Inhibition of Complement Factor D in Animal Models."

    Article Title: Induction of Ocular Complement Activation by Inflammatory Stimuli and Intraocular Inhibition of Complement Factor D in Animal Models.

    Journal: Investigative ophthalmology & visual science

    doi: 10.1167/iovs.17-22605

    FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing polyclonal antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.
    Figure Legend Snippet: FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing polyclonal antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.

    Techniques Used: Activation Assay, Injection, Clinical Proteomics, Western Blot, Control



    Similar Products

    polyclonal igg human  (Bio-Rad)
    93
    Bio-Rad polyclonal igg human
    Polyclonal Igg Human, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+fd+goat+polyclonal+antibody/pm34866215-87-11--1?v=Bio-Rad
    Average 93 stars, based on 1 article reviews
    polyclonal igg human - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    anti human fd goat polyclonal antibody  (R&D Systems)
    94
    R&D Systems anti human fd goat polyclonal antibody
    FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing <t>polyclonal</t> antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.
    Anti Human Fd Goat Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+fd+goat+polyclonal+antibody/pm29450541-82-6-12?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    anti human fd goat polyclonal antibody - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    anti human polyclonal antibody igg1  (SouthernBiotech)
    93
    SouthernBiotech anti human polyclonal antibody igg1
    FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing <t>polyclonal</t> antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.
    Anti Human Polyclonal Antibody Igg1, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+fd+goat+polyclonal+antibody/pm11748970-62-0-9?v=SouthernBiotech
    Average 93 stars, based on 1 article reviews
    anti human polyclonal antibody igg1 - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    human polyclonal igg  (Bio-Rad)
    93
    Bio-Rad human polyclonal igg
    FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing <t>polyclonal</t> antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.
    Human Polyclonal Igg, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+fd+goat+polyclonal+antibody/pmc02326891-78-11-14?v=Bio-Rad
    Average 93 stars, based on 1 article reviews
    human polyclonal igg - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    polyclonal goat antihamster igg  (SouthernBiotech)
    86
    SouthernBiotech polyclonal goat antihamster igg
    FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing <t>polyclonal</t> antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.
    Polyclonal Goat Antihamster Igg, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+fd+goat+polyclonal+antibody/pm08560196-30-1-5?v=SouthernBiotech
    Average 86 stars, based on 1 article reviews
    polyclonal goat antihamster igg - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing polyclonal antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.

    Journal: Investigative ophthalmology & visual science

    Article Title: Induction of Ocular Complement Activation by Inflammatory Stimuli and Intraocular Inhibition of Complement Factor D in Animal Models.

    doi: 10.1167/iovs.17-22605

    Figure Lengend Snippet: FIGURE 6. Intravitreal administration of an antibody against complement factor D inhibits LPS-induced Ba generation in rabbits in the posterior segment of the eye, but not systemically or in the anterior segment of the eye. (A) MAC deposition after Zymosan-induced alternative pathway activation in 6% human serum (solid line) or rabbit serum (dotted line) was blocked by a FD-neutralizing polyclonal antibody with IC50 values of 8.1 and 4.9 nM, respectively. Twenty-four hours before LPS challenge, goat IgG or anti-FD was delivered IVT at 200 lg per eye to both eyes. Eighteen hours after intravenous injection of either PBS or LPS at 20 lg/kg, plasma (D) and eye tissue were collected. Eyes were dissected immediately into vitreous humor (B), retina/RPE/choroid (C), aqueous humor (E), and iris/ciliary (CB) (F). Complement Ba levels in indicated tissues were measured by Western blot and graphed relative to the IgG/PBS control group. LPS-induced Ba generation was inhibited 100% (P < 0.01) in vitreous humor and was reduced by 60% (P < 0.01) of PBS control levels in retina/RPE/choroid. The rabbit LPS study is a representative of two independent studies.

    Article Snippet: A 7- point serial dilution of anti-human FD goat polyclonal antibody (AF1824, R&D Systems) starting at a concentration of 130 nM (final concentration in reaction) was prepared in saline.

    Techniques: Activation Assay, Injection, Clinical Proteomics, Western Blot, Control